Samuel Lafayette Murphy SEC EDGAR Filings (CIK 0001846430)

SEC EDGAR filings, ownership reports, and insider transactions for Samuel Lafayette Murphy.

Business address
C/O Viracta Therapeutics, Inc., 2533 South Coast Hwy., Ste. 210, Cardiff, CA, 92007
Get insider transactions for this reporting owner
Samuel Lafayette Murphy has filed 5 SEC EDGAR filings since 24 Feb 2021

Latest Filings

Recent SEC filings for Samuel Lafayette Murphy including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 24 Jun 2024 20 Jun 2024 000-51531
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 09 Jun 2023 08 Jun 2023 000-51531
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Jun 2022 09 Jun 2022 000-51531
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 30 Mar 2021 26 Mar 2021 000-51531
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 24 Feb 2021 24 Feb 2021 000-51531

About this filer

Samuel Lafayette Murphy files with the SEC under CIK 0001846430. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages